Bayer’s (BAYRY) emodepside was granted FDA orphan designation as a treatment of whipworm infection caused by Trichuris trichiura, according to a post to the agency’s website.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- FMC, Bayer collaborate to bring Isoflex to European markets
- Elliott gauged investor interest in Bayer’s consumer health business, FT says
- Monsanto Owner Bayer (BAYRY) Slumps on $2B Roundup Penalty after Georgia Court Ruling
- Bayer ordered by Georgia, US jury to pay $2.1B over Roundup, Bloomberg says
- Northern Trust selected by Bayer as provider for carbon credit management